Article
Identification of circulating tumour DNA (ctDNA) from the liquid biopsy results: Findings from an observational cohort study
1 Jan 2023
Abstract excerpt
Liquid biopsies can be a rapid, cost-effective and non-invasive alternative to tumour biopsies for detecting genetic mutations in somatic tumours. Genetic profiling of liquid biopsies can also be used to identify novel antigens for targeted therapy, provide updated information on disease prognosis and evaluate treatment efficacy. In this study, we aimed to examine mutations that could be identified in liquid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
